HEADER CYTOSOLIC PROTEIN 04-JUL-20 6XNU TITLE CRYSTAL STRUCTURE OF CBPB PROTEIN (LMO1009) FROM LISTERIA TITLE 2 MONOCYTOGENES COMPND MOL_ID: 1; COMPND 2 MOLECULE: CBS DOMAIN-CONTAINING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LISTERIA MONOCYTOGENES; SOURCE 3 ORGANISM_TAXID: 1639; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS C-DI-AMP BINDING PROTEIN, CYTOSOLIC PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.LUO,L.TONG REVDAT 2 18-OCT-23 6XNU 1 REMARK REVDAT 1 09-SEP-20 6XNU 0 JRNL AUTH B.N.PETERSON,M.K.M.YOUNG,S.LUO,J.WANG,A.T.WHITELEY, JRNL AUTH 2 J.J.WOODWARD,L.TONG,J.D.WANG,D.A.PORTNOY JRNL TITL (P)PPGPP AND C-DI-AMP HOMEOSTASIS IS CONTROLLED BY CBPB IN JRNL TITL 2 LISTERIA MONOCYTOGENES. JRNL REF MBIO V. 11 2020 JRNL REFN ESSN 2150-7511 JRNL PMID 32843560 JRNL DOI 10.1128/MBIO.01625-20 REMARK 2 REMARK 2 RESOLUTION. 1.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.33 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 37648 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 1996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.3300 - 3.9000 0.98 2691 152 0.1858 0.1757 REMARK 3 2 3.9000 - 3.0900 1.00 2620 150 0.1872 0.2322 REMARK 3 3 3.0900 - 2.7000 1.00 2600 140 0.2169 0.2406 REMARK 3 4 2.7000 - 2.4600 1.00 2582 139 0.2119 0.2383 REMARK 3 5 2.4600 - 2.2800 1.00 2577 144 0.2036 0.2477 REMARK 3 6 2.2800 - 2.1500 1.00 2534 148 0.2004 0.2033 REMARK 3 7 2.1500 - 2.0400 1.00 2572 136 0.2011 0.2268 REMARK 3 8 2.0400 - 1.9500 1.00 2519 153 0.1980 0.2418 REMARK 3 9 1.9500 - 1.8700 1.00 2549 143 0.2025 0.2294 REMARK 3 10 1.8700 - 1.8100 1.00 2529 138 0.2158 0.2359 REMARK 3 11 1.8100 - 1.7500 1.00 2559 148 0.2371 0.3157 REMARK 3 12 1.7500 - 1.7000 1.00 2523 133 0.2629 0.2791 REMARK 3 13 1.7000 - 1.6600 0.99 2523 146 0.2510 0.2736 REMARK 3 14 1.6600 - 1.6200 0.90 2274 126 0.2538 0.2771 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.910 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6XNU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1000250468. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37711 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.620 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.04600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.39100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3LQN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES (PH 6.1), AND 17% MPD, REMARK 280 EVAPORATION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.13000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.32400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.98600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.32400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.13000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.98600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -35.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -12 REMARK 465 GLY A -11 REMARK 465 SER A -10 REMARK 465 SER A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 SER A -2 REMARK 465 SER A -1 REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 ILE A 2 REMARK 465 SER A 3 REMARK 465 ASN A 4 REMARK 465 ARG A 5 REMARK 465 PHE A 6 REMARK 465 GLY A 7 REMARK 465 GLN A 8 REMARK 465 PHE A 9 REMARK 465 ILE A 10 REMARK 465 ASP A 11 REMARK 465 GLU A 74 REMARK 465 ARG A 150 REMARK 465 MET B -12 REMARK 465 GLY B -11 REMARK 465 SER B -10 REMARK 465 SER B -9 REMARK 465 HIS B -8 REMARK 465 HIS B -7 REMARK 465 HIS B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 SER B -2 REMARK 465 SER B -1 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 ILE B 2 REMARK 465 SER B 3 REMARK 465 ASN B 4 REMARK 465 ARG B 5 REMARK 465 PHE B 6 REMARK 465 GLY B 7 REMARK 465 GLN B 8 REMARK 465 PHE B 9 REMARK 465 ILE B 10 REMARK 465 ASP B 11 REMARK 465 ASN B 12 REMARK 465 GLU B 13 REMARK 465 LEU B 14 REMARK 465 HIS B 143 REMARK 465 LEU B 144 REMARK 465 GLN B 145 REMARK 465 VAL B 146 REMARK 465 GLU B 147 REMARK 465 GLU B 148 REMARK 465 ASN B 149 REMARK 465 ARG B 150 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR B 141 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ILE B 142 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 99 -174.68 -174.77 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 201 DBREF1 6XNU A 1 150 UNP A0A1D2IWV8_LISMN DBREF2 6XNU A A0A1D2IWV8 1 150 DBREF1 6XNU B 1 150 UNP A0A1D2IWV8_LISMN DBREF2 6XNU B A0A1D2IWV8 1 150 SEQADV 6XNU MET A -12 UNP A0A1D2IWV INITIATING METHIONINE SEQADV 6XNU GLY A -11 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU SER A -10 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU SER A -9 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS A -8 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS A -7 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS A -6 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS A -5 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS A -4 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS A -3 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU SER A -2 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU SER A -1 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU GLY A 0 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU MET B -12 UNP A0A1D2IWV INITIATING METHIONINE SEQADV 6XNU GLY B -11 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU SER B -10 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU SER B -9 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS B -8 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS B -7 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS B -6 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS B -5 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS B -4 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU HIS B -3 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU SER B -2 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU SER B -1 UNP A0A1D2IWV EXPRESSION TAG SEQADV 6XNU GLY B 0 UNP A0A1D2IWV EXPRESSION TAG SEQRES 1 A 163 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 163 MET ILE SER ASN ARG PHE GLY GLN PHE ILE ASP ASN GLU SEQRES 3 A 163 LEU ALA ASP SER MET ILE SER ALA GLU LYS VAL ALA HIS SEQRES 4 A 163 VAL GLN LEU GLY ASN ASN LEU GLU HIS ALA LEU LEU VAL SEQRES 5 A 163 LEU THR LYS CYS GLY TYR SER VAL ILE PRO VAL LEU ASP SEQRES 6 A 163 PHE GLU PHE LYS LEU HIS GLY LEU ILE SER ALA ALA MET SEQRES 7 A 163 ILE THR ASP ALA ILE LEU GLY LEU GLU ARG ILE GLU PHE SEQRES 8 A 163 GLU ARG LEU GLU ASP LEU LYS VAL GLU ASP VAL MET GLN SEQRES 9 A 163 THR ASP PHE PRO VAL ILE LYS ASP PHE ASN ASN ASN GLU SEQRES 10 A 163 ARG ILE VAL HIS LEU LEU VAL ASP HIS PRO PHE VAL CYS SEQRES 11 A 163 VAL VAL ASP SER ASP HIS HIS PHE GLU GLY ILE VAL THR SEQRES 12 A 163 ARG ARG VAL VAL LEU LYS GLN VAL ASN ARG TYR ILE HIS SEQRES 13 A 163 LEU GLN VAL GLU GLU ASN ARG SEQRES 1 B 163 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 163 MET ILE SER ASN ARG PHE GLY GLN PHE ILE ASP ASN GLU SEQRES 3 B 163 LEU ALA ASP SER MET ILE SER ALA GLU LYS VAL ALA HIS SEQRES 4 B 163 VAL GLN LEU GLY ASN ASN LEU GLU HIS ALA LEU LEU VAL SEQRES 5 B 163 LEU THR LYS CYS GLY TYR SER VAL ILE PRO VAL LEU ASP SEQRES 6 B 163 PHE GLU PHE LYS LEU HIS GLY LEU ILE SER ALA ALA MET SEQRES 7 B 163 ILE THR ASP ALA ILE LEU GLY LEU GLU ARG ILE GLU PHE SEQRES 8 B 163 GLU ARG LEU GLU ASP LEU LYS VAL GLU ASP VAL MET GLN SEQRES 9 B 163 THR ASP PHE PRO VAL ILE LYS ASP PHE ASN ASN ASN GLU SEQRES 10 B 163 ARG ILE VAL HIS LEU LEU VAL ASP HIS PRO PHE VAL CYS SEQRES 11 B 163 VAL VAL ASP SER ASP HIS HIS PHE GLU GLY ILE VAL THR SEQRES 12 B 163 ARG ARG VAL VAL LEU LYS GLN VAL ASN ARG TYR ILE HIS SEQRES 13 B 163 LEU GLN VAL GLU GLU ASN ARG HET CL A 201 1 HETNAM CL CHLORIDE ION FORMUL 3 CL CL 1- FORMUL 4 HOH *155(H2 O) HELIX 1 AA1 ASN A 12 SER A 17 1 6 HELIX 2 AA2 GLU A 22 VAL A 24 5 3 HELIX 3 AA3 ASN A 32 GLY A 44 1 13 HELIX 4 AA4 ALA A 63 ILE A 70 1 8 HELIX 5 AA5 GLU A 77 ASP A 83 5 7 HELIX 6 AA6 LYS A 85 MET A 90 1 6 HELIX 7 AA7 ASN A 102 HIS A 113 1 12 HELIX 8 AA8 ARG A 131 ASN A 149 1 19 HELIX 9 AA9 GLU B 22 VAL B 24 5 3 HELIX 10 AB1 ASN B 32 GLY B 44 1 13 HELIX 11 AB2 ALA B 63 ILE B 70 1 8 HELIX 12 AB3 GLU B 77 ASP B 83 5 7 HELIX 13 AB4 LYS B 85 MET B 90 1 6 HELIX 14 AB5 ASN B 102 HIS B 113 1 12 HELIX 15 AB6 ARG B 131 ILE B 142 1 12 SHEET 1 AA1 4 ILE A 19 SER A 20 0 SHEET 2 AA1 4 PHE A 125 THR A 130 -1 O ILE A 128 N ILE A 19 SHEET 3 AA1 4 PHE A 115 VAL A 119 -1 N VAL A 118 O GLY A 127 SHEET 4 AA1 4 VAL A 96 ILE A 97 1 N ILE A 97 O VAL A 119 SHEET 1 AA2 3 VAL A 27 GLN A 28 0 SHEET 2 AA2 3 VAL A 47 LEU A 51 1 O LEU A 51 N VAL A 27 SHEET 3 AA2 3 LEU A 57 SER A 62 -1 O GLY A 59 N VAL A 50 SHEET 1 AA3 4 ILE B 19 SER B 20 0 SHEET 2 AA3 4 PHE B 125 THR B 130 -1 O ILE B 128 N ILE B 19 SHEET 3 AA3 4 PHE B 115 VAL B 119 -1 N VAL B 118 O GLY B 127 SHEET 4 AA3 4 VAL B 96 ILE B 97 1 N ILE B 97 O VAL B 119 SHEET 1 AA4 3 VAL B 27 GLN B 28 0 SHEET 2 AA4 3 VAL B 47 LEU B 51 1 O LEU B 51 N VAL B 27 SHEET 3 AA4 3 LEU B 57 SER B 62 -1 O HIS B 58 N VAL B 50 SITE 1 AC1 2 ARG A 131 ARG B 131 CRYST1 54.260 71.972 74.648 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018430 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013894 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013396 0.00000